BMO Capital analyst Alex Arfaei call Eli Lilly's (NYSE: LLY) acquisition of ARMO 'incrementally positive' and makes them a probable ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE